What is Barclays's price target for SYNH?

Barclays's latest stated price target for Syneos Health Inc. (SYNH) is $25, from its action on Jan 17, 2023.

What is Barclays's rating on SYNH?

Barclays rates SYNH Underweight, a bearish rating, as of Jan 17, 2023.

When did Barclays last change its view on SYNH?

On Jan 17, 2023, Barclays downgrades to Underweight from Overweight, price target $30 to $25.

Barclays SYNH price target and rating history

Barclays rates Syneos Health Inc. (SYNH) Underweight with a $25 price target, as of its latest action on Jan 17, 2023. It has published 5 rating actions on SYNH since July 2021, including 1 upgrade and 2 downgrades.

Current rating: Underweight
Price target: $25
Median target, all firms: Too few
Actions on SYNH: 5

Barclays price target on SYNH

Barclays price target on SYNH, each point a stated target, July 2021 to January 2023.

Every Barclays rating on SYNH

Jan 17, 2023
DowngradeBarclays downgrades to Underweight from Overweight, price target $30 to $25
Jan 13, 2023
DowngradeBarclays downgrades to Underweight from Overweight, price target $25
Jan 27, 2022
ReiterateBarclays cuts its price target to $105 from $115, keeps Overweight
Nov 5, 2021
UpgradeBarclays upgrades to Overweight from Equal-Weight, price target $98 to $115
Jul 13, 2021
ReiterateBarclays raises its price target to $102 from $90, keeps Equal-Weight

Questions about Barclays and SYNH

What is Barclays's price target for SYNH?: Barclays's latest stated price target for Syneos Health Inc. (SYNH) is $25, from its action on Jan 17, 2023.
What is Barclays's rating on SYNH?: Barclays rates SYNH Underweight, a bearish rating, as of Jan 17, 2023.
When did Barclays last change its view on SYNH?: On Jan 17, 2023, Barclays downgrades to Underweight from Overweight, price target $30 to $25.

All Barclays ratings SYNH news and filings Every analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.